Microfabricated catheter with improved bonding structure

Information

  • Patent Grant
  • 9808595
  • Patent Number
    9,808,595
  • Date Filed
    Tuesday, August 7, 2007
    17 years ago
  • Date Issued
    Tuesday, November 7, 2017
    7 years ago
Abstract
Medical devices and methods for making and using the same. An example medical device may include a tubular member and a liner disposed within the tubular member. The tubular member may have a plurality of slots formed therein. A space may be defined between the tubular member and the liner. One or more bonding members may be disposed in the space.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS

The application is related to U.S. Pat. No. 7,001,369 and U.S. Patent Application Publication No. US 2006/0264904, the entire disclosures of which are herein incorporated by reference.


FIELD OF THE INVENTION

The present invention pertains to medical devices, and methods for manufacturing medical devices. More particularly, the present invention pertains to medical devices including a tubular member and a liner disposed within the tubular member.


BACKGROUND

A wide variety of intracorporeal medical devices have been developed for medical use, for example, intravascular use. Some of these devices include guidewires, catheters, and the like. These devices are manufactured by any one of a variety of different manufacturing methods and may be used according to any one of a variety of methods. Of the known medical devices and methods, each has certain advantages and disadvantages. There is an ongoing need to provide alternative medical devices as well as alternative methods for manufacturing and using medical devices.


BRIEF SUMMARY

The invention provides design, material, manufacturing method, and use alternatives for medical devices or components thereof. An example medical device may include a tubular member and a liner disposed within the tubular member. The tubular member may have a plurality of slots formed therein. A space may be defined between the inner surface of the tubular member and the outer surface of the liner. One or more bonding members may be disposed in the space to bond the tubular member to the liner.


The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present invention. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments





BRIEF DESCRIPTION OF THE DRAWINGS

The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:



FIG. 1 is a partial cross-sectional side view of an example medical device;



FIG. 2 is longitudinal cross-sectional side view of a portion of the example medical device shown in FIG. 1;



FIG. 3A is a transverse cross-sectional view taken through line A-A of FIG. 2;



FIG. 3B is a cross-sectional view of an alternative embodiment;



FIG. 3C is a cross-sectional view of an alternative embodiment;



FIG. 3D is a cross-sectional view of an alternative embodiment;



FIG. 3E is a cross-sectional view of a portion of example medical device;



FIG. 4 is a longitudinal cross-sectional view of a portion of another example medical device;



FIG. 5 is a longitudinal cross-sectional view of a portion of another example medical device;



FIG. 6 is a partial cross-sectional view of a portion of another example medical device;



FIG. 6A is a side view of a portion an example medical device; and



FIG. 6B is a side view of a portion an example medical device.





While the invention is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the invention to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the invention.


DETAILED DESCRIPTION

For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.


All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.


The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).


As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.


The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.



FIG. 1 illustrates an example medical device 10 in the form of a guide catheter. While medical device 10 is depicted as a catheter 10, it should be noted that this is for the purpose of illustration only. Device 10 may take the form of another medical device such as a catheter, a balloon catheter, an atherectomy catheter, a drug delivery catheter, a stent delivery catheter, a microcatheter, an endoscope, an introducer sheath, a fluid delivery device, other infusion or aspiration devices, device delivery (i.e. implantation) devices, and the like. In addition, device 10 may find utility in a variety of different procedures and at a variety of different target locations including blood vessels (coronary, peripheral, neurological, etc.), the digestive tract, the cerebral spinal space, and the like, or any other suitable location.


Catheter 10 may include a generally elongate shaft 12 having a longitudinal axis X, a proximal portion 14, and a distal portion 16. A proximal manifold 18 may be disposed at proximal portion 14. Manifold 18 may include a hub 20 and strain relief 22. A tip member 24 may be disposed at distal portion 16. Tip member 24 may include a radiopaque marker member 26. One or more additional marker members 26 may be disposed along other portions of catheter 10, for example along distal portion 16 of shaft 12. Shaft 12 may include a tubular member 28 having a plurality of slots 30 formed therein. Tubular member 28 may extend along the entire length of shaft 12 or any suitable portion of the length of shaft 12. Likewise, slots 30 may be disposed along a portion or all of tubular member 28. Some additional details regarding tubular member 28 and slots 30 can be found below.


Turning now to FIG. 2, here it can be seen that a tubular liner 32 may be disposed within tubular member 28. Liner 32 may have a length, an outer surface 34, and an inner surface 36. Inner surface 36 may define a lumen 38 that may be, for example, a guidewire lumen or other lumen for catheter 10. Liner 32 may extend along all or a portion of the length of tubular member 28. In some embodiments, liner 32 may extend distally out from tubular member 28 and form tip 24. In other embodiments, tip 24 and liner 32 may be distinct structures.


Liner 32 may generally comprise a polymeric material. Some examples of suitable polymeric materials are listed below. The polymeric material may be selected so as to provide inner surface 36 with the desired amount of lubricity so that devices (e.g., guidewires, etc.) can be manipulated within lumen 38. In some embodiments, liner 32 may be single layer of material. In other embodiments, liner 32 may include a plurality of layers. For example, liner 32 may include an inner layer, an intermediate layer disposed about the inner layer, a reinforcing layer disposed about the intermediate layer, and an outer layer disposed about the reinforcing layer and the intermediate layer. It should be understood that more or fewer layers can be used, with or without one or more reinforcing layers, depending upon the desired characteristics of liner 32. Additionally, in other embodiments, the layers could be arranged differently to achieve desired properties.


In general, along at least a portion of the length of liner 32, outer surface 34 is spaced apart from an inner surface 40 of tubular member 28. In some embodiments, liner 32 is spaced apart from tubular member 28 along the entire length of liner 32. The spacing may define a void or space 42 between the outer surface 34 of liner 32 and the inner surface 40 of tubular member 28. Space 42 may be generally cylindrical in shape, annular in shape, or have any other suitable shape and, as such, it can have or otherwise define a volume.


One or more bonding members 44 may be disposed in space 42. In some embodiments, bonding members 44 are distinct structural elements (e.g., distinct from liner 32 and tubular member 28) that are disposed in space 42. For example, bonding member 44 may include an adhesive, solder, epoxy, a bonding substance, or the like, or any other suitable substance. Alternatively, bonding member 44 may reflect a bonding pattern or bonding region where a portion of liner 32 and/or tubular member 28 extends into space 42 as the result of a bonding procedure. For example, a bonding procedure such as welding, brazing, crimping, heat treating, or the like, or any other suitable procedure may cause a portion of liner 32 (and/or tubular member 28) to extend into space 42 (e.g., liner 32 may partially melt and extend into space 42 and contact tubular member 28) so as to define a bonding member 44. This later “bonding member” 44, in addition to being termed a bonding member, may be equally described as a bonding pattern, bonding configuration, bonding arrangement, etc. Regardless of whether or not bonding member 44 is a distinct structural element or not, the term “bonding member” 44, as used in this disclosure, is understood to mean either of the general configurations described above (i.e., distinct structural element or bonding pattern), to the extent applicable. Furthermore, even though bonding members 44 are depicted as distinct structural elements in the figures, they are not intended to being limit as such as they may actually be either configuration. Consequently, any of the illustrations of bonding member herein may be understood to be structurally-distinct bonding members or bonding members that represent a bonding pattern, bonding configuration, bonding arrangement, etc.


Bonding members 44 may contact and attach outer surface 34 of liner 32 with inner surface 40 of tubular member 28. In addition to attaching liner 32 to tubular member 28, bonding member 44 may have other desirable attributes. For example, bonding member 44 may comprise points of contact between tubular member 28 and liner 32 so that forces (e.g., torsional forces) can be transferred between tubular member 28 and liner 32. This may allow tubular member 28 and liner 32 to perform their respective functions more in unity with one another.


In general, bonding member 44 are arranged so that they occupy a certain amount or portion of the volume defined by space 42. In some embodiments, bonding members 44, in combination, may occupy 50% or more of the volume. In other embodiments, bonding members 44, in combination, may occupy 50% or less of the volume. In still other embodiments, bonding members 44, in combination, may occupy 40% or less of the volume. In still other embodiments, bonding members 44, in combination, may occupy 30% or less of the volume. In still other embodiments, bonding members 44, in combination, may occupy 20% or less of the volume. In still other embodiments, bonding members 44, in combination, may occupy 10% or less of the volume. In some embodiments, it may be desirable for bonding members 44, in combination, to occupy as little of the volume of space 42 as possible while still allowing for tubular member 28 and liner 32 to function in a desirable manner and so that they satisfactorily perform their intended function.


The arrangement and configuration of bonding members 44 relative to liner 32 may also vary. For example, in some embodiments, bonding members 44 may extend circumferentially about (e.g., a complete 360 degrees) liner 32 as shown in FIG. 3A. In other embodiments, bonding members 44 may extend only partially circumferentially about (e.g., less than 360 degrees) a portion of liner 32. For example, FIG. 3B illustrates a portion of another shaft 12′, which may be similar in form and function to other shafts disclosed herein, where bonding members 44 extends about half way about the circumference of liner 32. It can be appreciated that embodiments are contemplated where bonding members 44 span all or any suitable portion of the circumference of liner 32 (e.g., ranging anywhere up to 360 degrees). In some embodiments, all of the bonding members 44 extend about the same portion, or all, of the circumference of liner 32. In other embodiments, some of the bonding members 44 extend about different portions of the circumference of liner 32. Various catheters 10 are contemplated that include various arrangements of bonding members 44 including any of those arrangements disclosed herein and/or combinations of the various arrangements disclosed herein.


Turning now to FIGS. 3C-3E, here additional example shafts 12″/12′″/12″″ are shown where multiple bonding members 44 are disposed at the same longitudinal location along the liner 32. For example, shaft 12″ is shown in FIG. 3C with a pair of bonding members 44 disposed opposite one another (e.g., with their centers 180 degrees apart) at the same location along liner 32. Shaft 12′″, as shown in FIG. 3D, depicts another pair of bonding members 44 disposed opposite one another at the same location along liner 32. The pair of bonding members 44 in FIG. 3D, however, are rotated relative to the pair of bonding members 44 in FIG. 3C. In FIG. 3E, three bonding members 44a/44b/44c are shown equally spaced about liner 32.


In some embodiments, all of the pairs of bonding members 44 are arranged in the same way so that one of the bonding members 44 from each pair longitudinally aligns. In other embodiments, at least some of the pairs of bonding members 44 are rotated relative to other pairs. For example, some embodiments of catheters 10 include a first pair of bonding members 44 arranged as shown in FIG. 3C and a next adjacent pair spaced longitudinally from the first pair that are rotated relative to the first pair (e.g., arranged as shown in FIG. 3D). The next longitudinally adjacent pair may be rotated like either of the previous two or it may have a different arrangement altogether. It can be appreciated that similar variations are contemplated for groups of bonding members 44 that include 3, 4, 5, 6, or more bonding members 44 disposed at the same longitudinal location along liner 32.


Moreover, when bonding members 44 are arranged in pairs (or otherwise in groups that are disposed at the same longitudinal location), the bonding members 44 may each have the same “length” (i.e., they each extend the same radial distance about liner 32) as depicted in FIGS. 3C and 3D. This, however, need not be the case as numerous catheters are contemplated where pairs or groups of bonding members 44 have different lengths. In addition, the relative lengths of the bonding members 44 in one group may or may not be similar to other groups of bonding members 44.


Furthermore, in some embodiments, all of the groups of bonding members 44 have the same number of bonding members 44. In other embodiments, some of the groups of bonding members 44 have a different number of bonding members 44.


It can be appreciated that a vast array of possibilities exist for the arrangement of bonding members 44 that are within the spirit of the invention.


In some embodiments, the interval or distance between longitudinally adjacent bonding members 44 is fixed along the length of liner 32. For example, in some embodiments, the interval between longitudinally adjacent bonding members is in the range of about 15 centimeters or less, about 14 centimeters or less, about 13 centimeters or less, about 12 centimeters or less, about 11 centimeters or less, about 10 centimeters or less, about 9 centimeters or less, about 8 centimeters or less, about 7 centimeters or less, about 6 centimeters or less, about 5 centimeters or less, about 4 centimeters or less, about 3 centimeters or less, about 2 centimeters or less, about 1 centimeter or less, or any other suitable interval. This interval may be constant or may change along the length of liner 32. In at least some embodiments, at least a portion of the tubular member 28 overlaps with liner 34 and defines an overlapping portion. Along the overlapping portion, there may be at least one bonding member 44 disposed at intervals of about every 15 centimeters or less, about every 14 centimeters or less, about every 13 centimeters or less, about every 12 centimeters or less, about every 11 centimeters or less, about every 10 centimeters or less, about every 9 centimeters or less, about every 8 centimeters or less, about every 7 centimeters or less, about every 6 centimeters or less, about every 5 centimeters or less, about every 4 centimeters or less, about every 3 centimeters or less, about every 2 centimeters or less, about every 1 centimeter or less, or any other suitable interval along at least a portion of or the entire length of the overlapping portion.


In other embodiments, the interval can change along a portion or all of the length of liner 32. For example, FIGS. 4 and 5 illustrate alternative arrangements of bonding members wherein the number of bonding members changes per unit length of liner 32 along at least a portion of liner 32. For example, FIG. 4 illustrates another shaft 112, which may be similar in form and function to other shafts disclosed herein, where the number of bonding members 144a/144b/144c/144d/144e per unit length increases along the length of liner 32. This increase may occur in a regular, irregular, stepwise, or any other manner. Similarly, in FIG. 5 another shaft 212 is shown, which may be similar in form and function to other shafts disclosed herein, where the number of bonding members 244a/244b/244c/244d/244e per unit length decreases along the length of liner 32. It can be appreciated that other embodiments are contemplated where multiple changes in the number of bonding members per unit length occur along liner 32.


Turning now to FIG. 6, another shaft 312 is shown that may be similar in form and function to other shafts disclosed herein. In this embodiment, bonding member 344 follows a helical or spiral pattern along the outer surface 34 of liner 32. As is the case for any of the bonding member disclosed herein, bonding member 344 may take the form of a distinct structure element (e.g., a helical or spiral ribbon) or bonding member 344 may be a helical bonding pattern, configuration, or arrangement.


The direction or orientation of bonding member 344 may vary. For example, in some embodiments, bonding member 344 may be arranged so that it is angled in the same, consistent, direction. The direction may be either slanted toward the proximal end or the distal end of shaft 312. In other embodiments, the orientation of bonding member 344 may vary. For example, some portions may be angled (i.e., the pitch may be angled) toward the proximal end of shaft 312 while other portions may be angled toward the distal end. Furthermore, some embodiments may include some portions that are angled in the same direction but at a different angle. It can be appreciated that numerous variations in the arrangement of bonding member 344 are contemplated.


Bonding member 344 may have a width that may in the range of about 0.1 to 10 millimeters. For example, bonding member 344 may be about 5 millimeters or less in width. In addition, the pitch of bonding member 344 may be about 0.1 to 10 centimeters or about 0.5 to 5 centimeters. These dimensions are provided for illustration purpose and are not intended to be limiting.


As illustrated in FIG. 6, bonding member 344 may be continuous. For example, bonding member may follow an unbroken or continuous pattern about liner 34. The pattern may take the form of a helix or spiral. In some embodiments, the helix may have a constant pitch. In other embodiments, the pitch may vary along the length of bonding member 344. For example, bonding member 344 may include a first region having a first pitch and a second region having a second pitch different from the first pitch. Other variations in bonding member 344 are also contemplated. For example, some embodiments may include two or more helices. These embodiments may include a single, continuous bonding member 344 that extends in one direction and then loops back in the opposite direction to define two or more helices. Alternatively, these embodiments may include a plurality of bonding members 344 that define a plurality of helices. The plurality of helices (i.e., the plurality of bonding members 344 defining the plurality of helices) may be oriented in the same or similar directions, in opposite directions, or in any suitable combination of directions. In still other embodiments, a plurality of bonding members 344 may be arranged so as to define one (e.g., a non-continuous, serial arrangement of bonding members 344 that, collectively, define a helix) or more helices.


In other embodiments, bonding member 344 may include several discrete bonding members that, collectively, follow a helical or spiral pattern about liner 34. For example, one or more bonding members 344 may be disposed at a first longitudinal position, a second set of one or more bonding member 344 may be disposed at an adjacent longitudinal position, etc. The second and subsequent sets of bonding members 344 may rotate about liner 34 such that bonding members 344 follow a helical pattern. In some embodiments, adjacent sets of bonding member 344 may be rotated at an angle relative to one another. For example, adjacent sets of bonding member 344 may be rotated more than about 90 degrees, about 90 degrees or less, about 85 degrees or less, about 80 degrees or less, about 75 degrees or less, about 70 degrees or less, about 65 degrees or less, about 60 degrees or less, about 55 degrees or less, about 50 degrees or less, about 45 degrees or less, or any other suitable angle. Essentially any other suitable angle or arrangement may be utilized without departing from the spirit of the invention.


The arrangement of bonding member 344 may be related to the arrangement of slots 30. For example, various embodiments of arrangements and configurations of slots 30 are contemplated. In some embodiments, at least some, if not all of slots 30 are disposed at the same or a similar angle with respect to the longitudinal axis of the tubular member 28. Slots 30 can be disposed at an angle that is perpendicular, or substantially perpendicular, and/or can be characterized as being disposed in a plane that is normal to the longitudinal axis of tubular member 28. However, in other embodiments, slots 30 can be disposed at an angle that is not perpendicular, and/or can be characterized as being disposed in a plane that is not normal to the longitudinal axis of tubular member 28. Additionally, a group of one or more slots 30 may be disposed at different angles relative to another group of one or more slots 30. The distribution and/or configuration of slots 30 can also include, to the extent applicable, any of those disclosed in U.S. Pat. Publication No. US 2004/0181174, the entire disclosure of which is herein incorporated by reference.


Slots 30 may be provided to enhance the flexibility of tubular member 28 while still allowing for suitable torque transmission characteristics. Slots 30 may be formed such that one or more rings and/or turns interconnected by one or more segments and/or beams are formed in tubular member 28, and such rings and beams may include portions of tubular member 28 that remain after slots 30 are formed in the body of tubular member 28. Such an interconnected ring structure may act to maintain a relatively high degree of torsional stiffness, while maintaining a desired level of lateral flexibility. In some embodiments, some adjacent slots 30 can be formed such that they include portions that overlap with each other about the circumference of tubular member 28. In other embodiments, some adjacent slots 30 can be disposed such that they do not necessarily overlap with each other, but are disposed in a pattern that provides the desired degree of lateral flexibility.


Additionally, slots 30 can be arranged along the length of, or about the circumference of, tubular member 28 to achieve desired properties. For example, adjacent slots 30, or groups of slots 30, can be arranged in a symmetrical pattern, such as being disposed essentially equally on opposite sides about the circumference of tubular member 28, or can be rotated by an angle relative to each other about the axis of tubular member 28. Additionally, adjacent slots 30, or groups of slots 30, may be equally spaced along the length of tubular member 28, or can be arranged in an increasing or decreasing density pattern, or can be arranged in a non-symmetric or irregular pattern. Other characteristics, such as slot size, slot shape and/or slot angle with respect to the longitudinal axis of tubular member 28, can also be varied along the length of tubular member 28 in order to vary the flexibility or other properties. In other embodiments, moreover, it is contemplated that the portions of the tubular member, such as a proximal section, or a distal section, or the entire tubular member 28, may not include any such slots 30.


As suggested above, slots 30 may be formed in groups of two, three, four, five, or more slots 30, which may be located at substantially the same location along the axis of tubular member 28. Within the groups of slots 30, there may be included slots 30 that are equal in size (i.e., span the same circumferential distance around tubular member 28). In some of these as well as other embodiments, at least some slots 30 in a group are unequal in size (i.e., span a different circumferential distance around tubular member 28). Longitudinally adjacent groups of slots 30 may have the same or different configurations. For example, some embodiments of tubular member 28 include slots 30 that are equal in size in a first group and then unequally sized in an adjacent group. It can be appreciated that in groups that have two slots 30 that are equal in size, the beams (i.e., the portion of tubular member 28 remaining after slots 30 are formed therein) are aligned with the center of tubular member 28. Conversely, in groups that have two slots 30 that are unequal in size, the beams are offset from the center of tubular member 28. Some embodiments of tubular member 28 include only slots 30 that are aligned with the center of tubular member 28, only slots 30 that are offset from the center of tubular member 28, or slots 30 that are aligned with the center of tubular member 28 in a first group and offset from the center of tubular member 28 in another group. The amount of offset may vary depending on the depth (or length) of slots 30 and can include essentially any suitable distance.


Slots 30 can be formed by methods such as micro-machining, saw-cutting (e.g., using a diamond grit embedded semiconductor dicing blade), laser cutting, electron discharge machining, grinding, milling, casting, molding, chemically etching or treating, or other known methods, and the like. In some such embodiments, the structure of the tubular member 28 is formed by cutting and/or removing portions of the tube to form slots 30. Some example embodiments of appropriate micromachining methods and other cutting methods, and structures for tubular members including slots and medical devices including tubular members are disclosed in U.S. Pat. Publication Nos. US 2003/0069522 and US 2004/0181174-A2; and U.S. Pat. Nos. 6,766,720; and 6,579,246, the entire disclosures of which are herein incorporated by reference. Some example embodiments of etching processes are described in U.S. Pat. No. 5,106,455, the entire disclosure of which is herein incorporated by reference. It should be noted that the methods for manufacturing catheter 10 may include forming slots 30 in tubular member 28 using any of these or other manufacturing steps.


Numerous other arrangements are contemplated that take advantage of the various arrangements and/or configurations discussed above.


Referring back now to the arrangement of bonding member 344 relative to the arrangement of slots 30, slots 30 and/or the beams formed in tubular member 28 may follow a pattern about tubular member 28. For example, in some embodiments, the beams may follow a spiral or helical pattern about tubular member 28. In other embodiments, the beams may be longitudinally aligned, follow any other suitable pattern, or be disposed in any suitable arrangement.


Turning back now to FIG. 6 and turning also to FIGS. 6A and 6B, in some embodiments, bonding member 344 may follow, parallel, mimic, or otherwise be similar to a helical pattern followed by the beams. For example, both the groups of beams (e.g., the beams are labeled with reference number 31 in FIGS. 6A and 6B) and bonding member 344 may extend helically along the outer surface 34 of liner 32 in substantially the same direction (e.g., as depicted in FIG. 6 and FIG. 6A). In other embodiments, the beams and bonding member 344 may be oriented in different directions (e.g., as depicted in FIG. 6 and FIG. 6B). The bonding members of any of the other medical devices disclosed herein may also be related to the pattern of the beams.


With the above arrangements of various bonding members and the like in mind, it should be noted that any of the arrangements disclosed above can be combined with one another in various embodiments of catheters.


Other variations are contemplated for the various structures disclosed herein including suitable materials. Catheter 10 as well as the various components and variations thereof may include a number of different materials including metals, metal alloys, polymers (some examples of which are disclosed below), metal-polymer composites, combinations thereof, and the like, or any other suitable material. Some examples of suitable metals and metal alloys include stainless steel, such as 304V, 304L, and 316LV stainless steel; mild steel; nickel-titanium alloy such as linear-elastic and/or super-elastic nitinol; other nickel alloys such as nickel-chromium-molybdenum alloys (e.g., UNS: NO6625 such as INCONEL® 625, UNS: NO6022 such as HASTELLOY® C-22®, UNS: N10276 such as HASTELLOY® C276®, other HASTELLOY® alloys, and the like), nickel-copper alloys (e.g., UNS: NO4400 such as MONEL® 400, NICKELVAC® 400, NICORROS® 400, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nickel-molybdenum alloys (e.g., UNS: N10665 such as HASTELLOY® ALLOY B2®), other nickel-chromium alloys, other nickel-molybdenum alloys, other nickel-cobalt alloys, other nickel-iron alloys, other nickel-copper alloys, other nickel-tungsten or tungsten alloys, and the like; cobalt-chromium alloys; cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like); platinum enriched stainless steel; combinations thereof; and the like; or any other suitable material.


As alluded to above, within the family of commercially available nickel-titanium or nitinol alloys, is a category designated “linear elastic” or “non-super-elastic” which, although may be similar in chemistry to conventional shape memory and super elastic varieties, may exhibit distinct and useful mechanical properties. Linear elastic and/or non-super-elastic nitinol may be distinguished from super elastic nitinol in that the linear elastic and/or non-super-elastic nitinol does not display a substantial “superelastic plateau” or “flag region” in its stress/strain curve like super elastic nitinol does. Instead, in the linear elastic and/or non-super-elastic nitinol, as recoverable strain increases, the stress continues to increase in a substantially linear, or a somewhat, but not necessarily entirely linear relationship until plastic deformation begins or at least in a relationship that is more linear that the super elastic plateau and/or flag region that may be seen with super elastic nitinol. Thus, for the purposes of this disclosure linear elastic and/or non-super-elastic nitinol may also be termed “substantially” linear elastic and/or non-super-elastic nitinol.


In some cases, linear elastic and/or non-super-elastic nitinol may also be distinguishable from super elastic nitinol in that linear elastic and/or non-super-elastic nitinol may accept up to about 2-5% strain while remaining substantially elastic (e.g., before plastically deforming) whereas super elastic nitinol may accept up to about 8% strain before plastically deforming. Both of these materials can be distinguished from other linear elastic materials such as stainless steel (that can also can be distinguished based on its composition), which may accept only about 0.2-0.44% strain before plastically deforming.


In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy is an alloy that does not show any martensitelaustenite phase changes that are detectable by DSC and DMTA analysis over a large temperature range. For example, in some embodiments, there may be no martensite/austenite phase changes detectable by DSC and DMTA analysis in the range of about −60° C. to about 120° C. in the linear elastic and/or non-super-elastic nickel-titanium alloy. The mechanical bending properties of such material may therefore be generally inert to the effect of temperature over this very broad range of temperature. In some embodiments, the mechanical bending properties of the linear elastic and/or non-super-elastic nickel-titanium alloy at ambient or room temperature are substantially the same as the mechanical properties at body temperature, for example, in that they do not display a super-elastic plateau and/or flag region. In other words, across a broad temperature range, the linear elastic and/or non-super-elastic nickel-titanium alloy maintains its linear elastic and/or non-super-elastic characteristics and/or properties and has essentially no yield point.


In some embodiments, the linear elastic and/or non-super-elastic nickel-titanium alloy may be in the range of about 50 to about 60 weight percent nickel, with the remainder being essentially titanium. In some embodiments, the composition is in the range of about 54 to about 57 weight percent nickel. One example of a suitable nickel-titanium alloy is FHP-NT alloy commercially available from Furukawa Techno Material Co. of Kanagawa, Japan. Some examples of nickel titanium alloys are disclosed in U.S. Pat. Nos. 5,238,004 and 6,508,803, which are incorporated herein by reference. Other suitable materials may include ULTANIUM™ (available from Neo-Metrics) and GUM METAL™ (available from Toyota). In some other embodiments, a superelastic alloy, for example a superelastic nitinol can be used to achieve desired properties.


In at least some embodiments, portions or all of catheter 10, for example markers 26, may also be doped with, made of, or otherwise include a radiopaque material. Radiopaque materials are understood to be materials capable of producing a relatively bright image on a fluoroscopy screen or another imaging technique during a medical procedure. This relatively bright image aids the user of catheter 10 in determining its location. Some examples of radiopaque materials can include, but are not limited to, gold, platinum, palladium, tantalum, tungsten alloy, polymer material loaded with a radiopaque filler, and the like.


In some embodiments, a degree of MRI compatibility is imparted into catheter 10. For example, to enhance compatibility with Magnetic Resonance Imaging (MRI) machines, it may be desirable to make all or portions of catheter 10, in a manner that would impart a degree of MRI compatibility. For example, tubular member 28 or portions thereof, or any other portion of catheter 10, may be made of a material that does not substantially distort the image and create substantial artifacts (artifacts are gaps in the image). Certain ferromagnetic materials, for example, may not be suitable because they may create artifacts in an MRI image. Tubular member 28 or portions thereof, or any other portion of catheter 10, may also be made from a material that the MRI machine can image. Some materials that exhibit these characteristics include, for example, tungsten, cobalt-chromium-molybdenum alloys (e.g., UNS: R30003 such as ELGILOY®, PHYNOX®, and the like), nickel-cobalt-chromium-molybdenum alloys (e.g., UNS: R30035 such as MP35-N® and the like), nitinol, and the like, and others.


A sheath or covering (not shown) may be disposed over portions or all of catheter 10 that may define a generally smooth outer surface for catheter 10. In other embodiments, however, such a sheath or covering may be absent from a portion of all of catheter 10. The sheath may be made from a polymer or any other suitable material. Some examples of suitable polymers may include polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, DELRIN® available from DuPont), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, ARNITEL® available from DSM Engineering Plastics), ether or ester based copolymers (for example, butylene/poly(alkylene ether) phthalate and/or other polyester elastomers such as HYTREL® available from DuPont), polyamide (for example, DURETHAN® available from Bayer or CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example available under the trade name PEBAX®), ethylene vinyl acetate copolymers (EVA), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene (for example REXELL®), polyester, polybutylene terephthalate (PBT), polyethylene terephthalate (PET), polytrimethylene terephthalate, polyethylene naphthalate (PEN), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), poly paraphenylene terephthalamide (for example, KEVLAR®), polysulfone, nylon, nylon-12 (such as GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. In some embodiments the sheath can be blended with a liquid crystal polymer (LCP).


The sheath, if present, and/or liner 32 may be made from a lubricious, hydrophilic, protective, or other type of material. Alternatively, liner may include any other suitable material or combination of materials including any of those disclosed herein. Hydrophobic coatings such as fluoropolymers provide a dry lubricity which improves device handling and device exchanges. Lubricious coatings improve steerability and improve lesion crossing capability. Suitable lubricious polymers are well known in the art and may include silicone and the like, hydrophilic polymers such as high-density polyethylene (HDPE), polytetrafluoroethylene (PTFE), polyarylene oxides, polyvinylpyrolidones, polyvinylalcohols, hydroxy alkyl cellulosics, algins, saccharides, caprolactones, and the like, and mixtures and combinations thereof. Hydrophilic polymers may be blended among themselves or with formulated amounts of water insoluble compounds (including some polymers) to yield coatings with suitable lubricity, bonding, and solubility. Some other examples of such coatings and materials and methods used to create such coatings can be found in U.S. Pat. Nos. 6,139,510 and 5,772,609, which are incorporated herein by reference.


The coating and/or sheath may be formed, for example, by coating, extrusion, co-extrusion, interrupted layer co-extrusion (ILC), or fusing several segments end-to-end. The layer may have a uniform stiffness or a gradual reduction in stiffness from the proximal end to the distal end thereof. The gradual reduction in stiffness may be continuous as by ILC or may be stepped as by fusing together separate extruded tubular segments. The outer layer may be impregnated with a radiopaque filler material to facilitate radiographic visualization. Those skilled in the art will recognize that these materials can vary widely without deviating from the scope of the present invention.


It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the invention. The invention's scope is, of course, defined in the language in which the appended claims are expressed.

Claims
  • 1. A medical device, comprising: an elongated tubular member having a length, an inner surface defining a lumen, a proximal end, and a distal end, the tubular member including a monolithic body having a length and including a plurality of slots formed therein;a tubular liner disposed within the elongated tubular member, the liner having a length, an outer surface, and an inner surface defining a lumen, wherein the outer surface is spaced from the inner surface of the tubular member such that a space is defined therebetween;a plurality of discrete bonding members disposed in the space and attaching the elongated tubular member to the tubular liner, wherein each of the plurality of bonding members is within 15 centimeters or less of an adjacent bonding member along the length of the tubular member;wherein the plurality of discrete bonding members include a weld, adhesive bond, braze, crimp, solder bond, epoxy bond, bonding substance, thermal bond, or combinations thereof that fixedly attach the elongated tubular member to the tubular liner;wherein a first group of bonding members are disposed along a first portion of the liner to provide the medical device with a first flexibility, the first group of bonding members including a pair of bonding members disposed opposite each other at a first longitudinal position along the liner and a second group of bonding members are disposed along a second portion of the liner, the second group of bonding members having a different number of bonding members from the first group of bonding members, the second group of bonding members including three or more bonding members that are equally spaced about the liner at a second longitudinal position along the liner different from the first longitudinal position so as to provide the medical device with a second flexibility different from the first flexibility; andwherein the number of bonding members per unit length decreases along the length of the liner and forms a smooth transition between the first flexibility and the second flexibility.
  • 2. The medical device of claim 1, wherein the space has a volume and wherein the bonding members occupy 50% or less of the volume.
  • 3. The medical device of claim 1, wherein the space has a volume and wherein the bonding members occupy 40% or less of the volume.
  • 4. The medical device of claim 1, wherein the space has a volume and wherein the bonding members occupy 30% or less of the volume.
  • 5. The medical device of claim 1, wherein the space has a volume and wherein the bonding members occupy 20% or less of the volume.
  • 6. The medical device of claim 1, wherein the space has a volume and wherein the bonding members occupy 10% or less of the volume.
  • 7. The medical device of claim 1, wherein at least a portion of the space remains unfilled by the bonding members.
  • 8. The medical device of claim 1, wherein at least some of the bonding members extend circumferentially about the liner.
  • 9. The medical device of claim 1, wherein at least some of the bonding members extend only partially circumferentially about the liner.
  • 10. The medical device of claim 9, wherein two or more bonding members that extend only partially circumferentially about the liner are disposed at the same longitudinal position along the liner.
  • 11. The medical device of claim 9, wherein the pair of bonding members of the first group of bonding members is defined by a pair of partially circumferential bonding members disposed opposite one another at the same longitudinal position along the liner.
  • 12. The medical device of claim 11, wherein the three or more bonding members of the second group of bonding is defined by three or more partially circumferential bonding members disposed opposite one another at the same longitudinal position along the liner.
  • 13. The medical device of claim 1, wherein at least one of the bonding members includes a bonding member that extends helically along the outer surface of the liner.
  • 14. The medical device of claim 13, wherein groups of beams are defined in the tubular member between slots at the same longitudinal location, wherein the groups of beams follow a helical pattern about the tubular member, and wherein both the groups of beams and the bonding member that extends helically along the outer surface of the liner are oriented in substantially the same direction.
  • 15. The medical device of claim 13, wherein groups of beams are defined in the tubular member between slots at the same longitudinal location, wherein the groups of beams follow a helical pattern about the tubular member, and wherein both the groups of beams and the bonding member that extends helically along the outer surface of the liner are oriented in different directions.
  • 16. The medical device of claim 1, wherein each of the plurality of bonding members is within 10 centimeters or less of an adjacent bonding member along the length of the tubular member.
  • 17. The medical device of claim 1, wherein each of the plurality of bonding members is within 5 centimeters or less of an adjacent bonding member along the length of the tubular member.
  • 18. A medical device, comprising: an elongated tubular member having an inner surface defining a lumen, a proximal end, and a distal end, the tubular member including a monolithic body having a length and including a plurality of slots formed therein;a tubular liner disposed within at least a portion of the elongated tubular member such that the tubular member overlaps the liner along an overlapping portion having a length, the liner having an outer surface, and an inner surface defining a lumen, wherein the outer surface of the tubular liner is spaced from the inner surface of the elongated tubular member along the overlapping portion such that a space is defined therebetween; anda plurality of discrete, axially discontinuous bonding members disposed in the space and attaching the elongated tubular member to the tubular liner, wherein the plurality of bonding members are disposed such that there is at least one bonding member at intervals of 15 centimeters or less along the entire length of the overlapping portion;wherein the plurality of discrete bonding members physically, chemically, or both physically and chemically bond the elongated tubular member to the tubular liner;wherein at least some of the bonding members extend only partially circumferentially about the liner;wherein a first group of bonding members is defined that includes two or more bonding members that extend only partially circumferentially about the liner and are disposed at the same longitudinal position along the length of the liner; andwherein the bonding members decrease in frequency along the length of the liner so as to define a smooth transition in flexibility of the medical device along the length of the liner.
  • 19. The catheter of claim 18, wherein at least some of the bonding members extend circumferentially about the liner.
  • 20. The catheter of claim 18, wherein a second group of bonding members is defined adjacent the first group that includes two or more bonding members that extend only partially circumferentially about the liner and are disposed at the same longitudinal position along the length of the liner, wherein the second group is rotated relative to the first group.
  • 21. The catheter of claim 18, wherein the plurality of bonding members are disposed such that there is at least one bonding member at intervals of 10 centimeters or less along the entire length of the overlapping portion.
  • 22. The catheter of claim 18, wherein the plurality of bonding members are disposed such that there is at least one bonding member at intervals of 5 centimeters or less along the entire length of the overlapping portion.
US Referenced Citations (387)
Number Name Date Kind
1553227 Feyk et al. Sep 1925 A
1866888 Hawley Jul 1932 A
2275827 Plensler Mar 1942 A
2413805 Vickers Jan 1947 A
2441166 Raspert May 1948 A
2561890 Stoddard Jul 1951 A
2722614 Fryklund Nov 1955 A
2857536 Light Oct 1958 A
2864017 Waltscheff Dec 1958 A
2871793 Michie et al. Feb 1959 A
3249776 Anderson et al. May 1966 A
3322984 Anderson May 1967 A
3334253 Hill Aug 1967 A
3363470 Yavne Jan 1968 A
3452227 Welch Jun 1969 A
3452742 Muller Jul 1969 A
3463953 Maxwell Aug 1969 A
3512019 Durand May 1970 A
3544868 Bates Dec 1970 A
3625200 Muller Dec 1971 A
3686990 Margolien Aug 1972 A
3841308 Tate Oct 1974 A
3890977 Wilson Jun 1975 A
3906938 Fleischhacker Sep 1975 A
4000672 Sitterer et al. Jan 1977 A
4003369 Heilman et al. Jan 1977 A
4020829 Willson et al. May 1977 A
4142119 Madey Feb 1979 A
4215703 Wilson Aug 1980 A
4330725 Hintz May 1982 A
4425919 Alston, Jr. et al. Jan 1984 A
4476754 Ducret Oct 1984 A
4482828 Vergues et al. Nov 1984 A
4516972 Samson May 1985 A
4545390 Leary Oct 1985 A
4563181 Wijayarathna et al. Jan 1986 A
4574670 Johnson Mar 1986 A
4580551 Siegmund et al. Apr 1986 A
4583404 Bernard et al. Apr 1986 A
4635270 Gürs Jan 1987 A
4665906 Jervis May 1987 A
4676249 Arenas et al. Jun 1987 A
4721117 Mar et al. Jan 1988 A
4737153 Shimamura et al. Apr 1988 A
4763647 Gambale Aug 1988 A
4774949 Fogarty Oct 1988 A
4781092 Gaiser Nov 1988 A
4781186 Simpson et al. Nov 1988 A
4786220 Fildes et al. Nov 1988 A
4790331 Okada et al. Dec 1988 A
4800890 Cramer Jan 1989 A
4811743 Stevens Mar 1989 A
4827941 Taylor et al. May 1989 A
4831858 Yoshizawa May 1989 A
4832047 Sepetka et al. May 1989 A
4846186 Box et al. Jul 1989 A
4846193 Tremulis et al. Jul 1989 A
4867173 Leoni Sep 1989 A
4875489 Messner et al. Oct 1989 A
4884579 Engelson Dec 1989 A
4911148 Sosnowski et al. Mar 1990 A
4917102 Miller et al. Apr 1990 A
4922164 Jacobsen et al. May 1990 A
4922777 Kawabata May 1990 A
4932959 Horzewski et al. Jun 1990 A
4934380 Toledo Jun 1990 A
4953553 Tremulis Sep 1990 A
4954022 Underwood et al. Sep 1990 A
4955384 Taylor et al. Sep 1990 A
4955862 Sepetka Sep 1990 A
4960410 Pinchuk Oct 1990 A
4964409 Tremulis Oct 1990 A
4966163 Kraus et al. Oct 1990 A
4968306 Huss et al. Nov 1990 A
4973321 Michelson Nov 1990 A
4981478 Evard et al. Jan 1991 A
4985022 Fearnot et al. Jan 1991 A
4989608 Ratner Feb 1991 A
4990143 Sheridan Feb 1991 A
4994069 Ritchart et al. Feb 1991 A
4998923 Samson et al. Mar 1991 A
5007434 Doyle et al. Apr 1991 A
5009137 Dannatt Apr 1991 A
5040543 Badera et al. Aug 1991 A
5050606 Tremulis Sep 1991 A
5052404 Hodgson Oct 1991 A
5059177 Alcebo et al. Oct 1991 A
5063935 Gambale Nov 1991 A
5065769 De Toledo Nov 1991 A
5095915 Engelson Mar 1992 A
5106455 Jacobsen et al. Apr 1992 A
5109830 Cho May 1992 A
5125395 Adair Jun 1992 A
5135531 Shiber Aug 1992 A
5144959 Gambale et al. Sep 1992 A
5147317 Shank et al. Sep 1992 A
5176660 Truckai Jan 1993 A
5180376 Fischell Jan 1993 A
5181668 Tsuji et al. Jan 1993 A
5205830 Dassa et al. Apr 1993 A
5211183 Wilson May 1993 A
5228441 Lundquist Jul 1993 A
5238004 Sahatjian et al. Aug 1993 A
5242759 Hall Sep 1993 A
5243996 Hall Sep 1993 A
5250069 Nobuyoshi et al. Oct 1993 A
5254106 Feaster Oct 1993 A
5254107 Soltesz Oct 1993 A
5256144 Kraus et al. Oct 1993 A
5257974 Cox Nov 1993 A
5259393 Corso, Jr. et al. Nov 1993 A
5267979 Appling et al. Dec 1993 A
5267982 Sylvanowicz Dec 1993 A
5279562 Sirhan et al. Jan 1994 A
5284128 Hart Feb 1994 A
5300032 Hibbs et al. Apr 1994 A
5304131 Paskar Apr 1994 A
5306252 Yutori et al. Apr 1994 A
5308435 Ruggles et al. May 1994 A
5315906 Ferenczi et al. May 1994 A
5315996 Lundquist May 1994 A
5318529 Kontos Jun 1994 A
5322064 Lundquist Jun 1994 A
5329923 Lundquist Jul 1994 A
5333620 Moutafis et al. Aug 1994 A
5334145 Lundquist et al. Aug 1994 A
5336205 Zenzen et al. Aug 1994 A
5341818 Abrams et al. Aug 1994 A
5345937 Middleman et al. Sep 1994 A
5345945 Hodgson et al. Sep 1994 A
5354623 Hall Oct 1994 A
5358493 Schweich et al. Oct 1994 A
5358796 Nakamura et al. Oct 1994 A
5365942 Shank Nov 1994 A
5365943 Jansen Nov 1994 A
5368564 Savage Nov 1994 A
5368661 Nakamura et al. Nov 1994 A
5376084 Bacich et al. Dec 1994 A
5381782 DeLaRama et al. Jan 1995 A
5406960 Corso, Jr. Apr 1995 A
5411476 Abrams May 1995 A
5425723 Wang Jun 1995 A
5437288 Schwartz et al. Aug 1995 A
5438993 Lynch et al. Aug 1995 A
5439000 Gunderson et al. Aug 1995 A
5441483 Avitall Aug 1995 A
5441489 Utsumi et al. Aug 1995 A
5447812 Fukuda et al. Sep 1995 A
5454787 Lundquist Oct 1995 A
5454795 Samson Oct 1995 A
5458605 Klemm Oct 1995 A
5460187 Daigle et al. Oct 1995 A
5460608 Lodin et al. Oct 1995 A
5470330 Goldenberg et al. Nov 1995 A
5476701 Berger Dec 1995 A
5477856 Lundquist Dec 1995 A
5496294 Hergenrother et al. Mar 1996 A
5497785 Viera Mar 1996 A
5507301 Wasicek et al. Apr 1996 A
5507729 Lindenberg et al. Apr 1996 A
5507751 Goode et al. Apr 1996 A
5507766 Kugo et al. Apr 1996 A
5514128 Hillsman et al. May 1996 A
5520194 Miyata et al. May 1996 A
5520645 Imran et al. May 1996 A
5531719 Takahashi Jul 1996 A
5533985 Wang Jul 1996 A
5546958 Thorud et al. Aug 1996 A
5551444 Finlayson Sep 1996 A
5554139 Okajima Sep 1996 A
5562619 Mirarchi et al. Oct 1996 A
5569197 Helmus et al. Oct 1996 A
5569200 Umeno et al. Oct 1996 A
5569218 Berg Oct 1996 A
5571073 Castillo Nov 1996 A
5573520 Schwartz et al. Nov 1996 A
5584821 Hobbs et al. Dec 1996 A
5599326 Carter Feb 1997 A
5599492 Engelson Feb 1997 A
5601539 Corso, Jr. Feb 1997 A
5603705 Berg Feb 1997 A
5605162 Mirzaee et al. Feb 1997 A
5622184 Ashby et al. Apr 1997 A
5630806 Inagaki et al. May 1997 A
5637089 Abrams et al. Jun 1997 A
5656011 Uihlein et al. Aug 1997 A
5658264 Samson et al. Aug 1997 A
5666968 Imran et al. Sep 1997 A
5666969 Urick et al. Sep 1997 A
5669926 Aust et al. Sep 1997 A
5674208 Berg et al. Oct 1997 A
5676659 McGurk Oct 1997 A
5676697 McDonald Oct 1997 A
5680873 Berg et al. Oct 1997 A
5682894 Orr et al. Nov 1997 A
5690120 Jacobsen et al. Nov 1997 A
5702373 Samson Dec 1997 A
5720300 Fagan et al. Feb 1998 A
5722609 Murakami Mar 1998 A
5728063 Preissman et al. Mar 1998 A
5733248 Adams et al. Mar 1998 A
5741429 Donadio, III et al. Apr 1998 A
5746701 Noone May 1998 A
5769830 Parker Jun 1998 A
5772609 Nguyen et al. Jun 1998 A
5782809 Umeno et al. Jul 1998 A
5788653 Lorenzo Aug 1998 A
5788654 Schwager Aug 1998 A
5788707 Del Toro et al. Aug 1998 A
5792124 Horrigan et al. Aug 1998 A
5797856 Frisbie et al. Aug 1998 A
5800454 Jacobsen et al. Sep 1998 A
5807075 Jacobsen et al. Sep 1998 A
5807249 Qin et al. Sep 1998 A
5810885 Zinger Sep 1998 A
5813996 St. Germain et al. Sep 1998 A
5827225 Ma Schwab Oct 1998 A
5827242 Follmer et al. Oct 1998 A
5830155 Frechette et al. Nov 1998 A
5833631 Nguyen Nov 1998 A
5833632 Jacobsen et al. Nov 1998 A
5836926 Peterson et al. Nov 1998 A
5843050 Jones et al. Dec 1998 A
5843244 Pelton et al. Dec 1998 A
5851203 van Muiden Dec 1998 A
5853400 Samson Dec 1998 A
5860963 Azam et al. Jan 1999 A
5891114 Chien et al. Apr 1999 A
5895378 Nita Apr 1999 A
5897537 Berg et al. Apr 1999 A
5902254 Magram May 1999 A
5902290 Peacock, III et al. May 1999 A
5904657 Unsworth et al. May 1999 A
5906618 Larson, III May 1999 A
5911715 Berg et al. Jun 1999 A
5911717 Jacobsen et al. Jun 1999 A
5916177 Schwager Jun 1999 A
5916178 Noone Jun 1999 A
5916194 Jacobsen et al. Jun 1999 A
5931830 Jacobsen et al. Aug 1999 A
5935108 Katoh et al. Aug 1999 A
5947940 Beisel Sep 1999 A
5951539 Nita et al. Sep 1999 A
5971975 Mills et al. Oct 1999 A
5980471 Jafari Nov 1999 A
6001068 Uchino et al. Dec 1999 A
6004279 Crowley et al. Dec 1999 A
6014919 Jacobsen et al. Jan 2000 A
6017319 Jacobsen et al. Jan 2000 A
6022343 Johnson et al. Feb 2000 A
6022369 Jacobsen et al. Feb 2000 A
6024730 Pagan Feb 2000 A
6027461 Walker et al. Feb 2000 A
6042553 Solar et al. Mar 2000 A
6045547 Ren et al. Apr 2000 A
6048339 Zirps et al. Apr 2000 A
6053903 Samson Apr 2000 A
6056702 Lorenzo May 2000 A
6063101 Jacobsen et al. May 2000 A
6063200 Jacobsen et al. May 2000 A
6066361 Jacobsen et al. May 2000 A
6106485 McMahon Aug 2000 A
6106488 Fleming et al. Aug 2000 A
6139510 Palermo Oct 2000 A
6152912 Jansen et al. Nov 2000 A
6159187 Park et al. Dec 2000 A
6165292 Abrams et al. Dec 2000 A
6171296 Chow Jan 2001 B1
6183410 Jacobsen et al. Feb 2001 B1
6193686 Estrada et al. Feb 2001 B1
6197014 Samson et al. Mar 2001 B1
6203485 Urick Mar 2001 B1
RE37148 Shank Apr 2001 E
6212422 Berg et al. Apr 2001 B1
6214042 Jacobsen et al. Apr 2001 B1
6228073 Noone et al. May 2001 B1
6240231 Ferrera et al. May 2001 B1
6248082 Jafari Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6254549 Ramzipoor Jul 2001 B1
6260458 Jacobsen et al. Jul 2001 B1
6273404 Holman et al. Aug 2001 B1
6273876 Klima et al. Aug 2001 B1
6273879 Keith et al. Aug 2001 B1
6290656 Boyle et al. Sep 2001 B1
6296616 McMahon Oct 2001 B1
6296631 Chow Oct 2001 B2
6302870 Jacobsen et al. Oct 2001 B1
6325790 Trotta Dec 2001 B1
6338725 Hermann et al. Jan 2002 B1
6346091 Jacobsen et al. Feb 2002 B1
6352515 Anderson et al. Mar 2002 B1
6355005 Powell et al. Mar 2002 B1
6355027 Le et al. Mar 2002 B1
6368315 Gillis et al. Apr 2002 B1
6368316 Jansen et al. Apr 2002 B1
6375628 Zadno-Azizi et al. Apr 2002 B1
6375774 Lunn et al. Apr 2002 B1
6379369 Abrams et al. Apr 2002 B1
6390993 Cornish et al. May 2002 B1
6398758 Jacobsen et al. Jun 2002 B1
6428489 Jacobsen et al. Aug 2002 B1
6428512 Anderson et al. Aug 2002 B1
6431039 Jacobsen et al. Aug 2002 B1
6440088 Jacobsen Aug 2002 B1
6478778 Jacobsen et al. Nov 2002 B1
6488637 Eder et al. Dec 2002 B1
6491648 Cornish et al. Dec 2002 B1
6491671 Larson, III et al. Dec 2002 B1
6503244 Hayman Jan 2003 B2
6508803 Horikawa et al. Jan 2003 B1
6508806 Hoste Jan 2003 B1
6524301 Wilson et al. Feb 2003 B1
6530934 Jacobsen et al. Mar 2003 B1
6547779 Levine et al. Apr 2003 B2
6553880 Jacobsen et al. Apr 2003 B2
6556873 Smits Apr 2003 B1
6579246 Jacobsen et al. Jun 2003 B2
6602207 Mann et al. Aug 2003 B1
6602280 Chobotov Aug 2003 B2
6610046 Usami et al. Aug 2003 B1
6623448 Slater Sep 2003 B2
6636758 Sanchez et al. Oct 2003 B2
6638266 Wilson et al. Oct 2003 B2
6652508 Griffin et al. Nov 2003 B2
6682493 Mirigian Jan 2004 B2
6689120 Gerdts Feb 2004 B1
6702762 Jafari et al. Mar 2004 B2
6712826 Lui Mar 2004 B2
6730095 Olson, Jr. et al. May 2004 B2
6746422 Noriega Jun 2004 B1
6749560 Konstorum et al. Jun 2004 B1
6766720 Jacobsen et al. Jul 2004 B1
6777644 Peacock, III et al. Aug 2004 B2
6811544 Schaer Nov 2004 B2
6837898 Boyle et al. Jan 2005 B2
6866642 Kellerman et al. Mar 2005 B2
6866665 Orbay Mar 2005 B2
6887235 O'Connor et al. May 2005 B2
6896671 Vitullo et al. May 2005 B2
6918882 Skujins et al. Jul 2005 B2
6997937 Jacobsen et al. Feb 2006 B2
7001369 Griffin et al. Feb 2006 B2
7074197 Reynolds et al. Jul 2006 B2
7153277 Skujins et al. Dec 2006 B2
7182735 Shireman et al. Feb 2007 B2
7850623 Griffin Dec 2010 B2
20020013540 Jacobsen et al. Jan 2002 A1
20020019599 Rooney et al. Feb 2002 A1
20030009208 Snyder et al. Jan 2003 A1
20030060732 Jacobsen et al. Mar 2003 A1
20030069522 Jacobsen Apr 2003 A1
20030216668 Howland et al. Nov 2003 A1
20040045645 Zhou Mar 2004 A1
20040082879 Klint Apr 2004 A1
20040116831 Vrba Jun 2004 A1
20040142643 Miller et al. Jul 2004 A1
20040167436 Reynolds et al. Aug 2004 A1
20040167437 Sharrow et al. Aug 2004 A1
20040167440 Sharrow Aug 2004 A1
20040167441 Reynolds et al. Aug 2004 A1
20040181174 Davis et al. Sep 2004 A2
20040181176 Jafari et al. Sep 2004 A1
20040181207 Vitullo et al. Sep 2004 A1
20040193140 Griffin et al. Sep 2004 A1
20050027309 Shiber Feb 2005 A1
20050177073 Shiber Aug 2005 A1
20050288628 Jordan et al. Dec 2005 A1
20060111649 Zhou May 2006 A1
20060121218 Obara et al. Jun 2006 A1
20060122537 Reynolds et al. Jun 2006 A1
20060189896 Davis et al. Aug 2006 A1
20060264904 Kerby et al. Nov 2006 A1
20070100285 Griffin et al. May 2007 A1
20070100424 Chew et al. May 2007 A1
20080021347 Jacobsen et al. Jan 2008 A1
20080021348 Jacobsen et al. Jan 2008 A1
20080021400 Jacobsen et al. Jan 2008 A1
20080021401 Jacobsen et al. Jan 2008 A1
20080021402 Jacobsen et al. Jan 2008 A1
20080021403 Jacobsen et al. Jan 2008 A1
20080021404 Jacobsen et al. Jan 2008 A1
20080021405 Jacobsen et al. Jan 2008 A1
20080021406 Jacobsen et al. Jan 2008 A1
20080021407 Jacobsen et al. Jan 2008 A1
20080021408 Jacobsen et al. Jan 2008 A1
20080077119 Snyder et al. Mar 2008 A1
Foreign Referenced Citations (142)
Number Date Country
723040 Dec 1997 AU
733966 Apr 1998 AU
9712829 Jan 2000 BR
2266685 May 2006 CA
2255781 Mar 2007 CA
1230914 Oct 1999 CN
2539191 Mar 1976 DE
285514 Dec 1990 DE
0 045 931 Feb 1982 EP
0 069 522 Jan 1983 EP
0 087 933 Sep 1983 EP
0 111 044 Jun 1984 EP
0 181 174 May 1986 EP
0 377 453 Jul 1990 EP
0 565 065 Jun 1996 EP
0 778 038 Jun 1997 EP
0 778 039 Jun 1997 EP
0 778 040 Jun 1997 EP
0 812 599 Dec 1997 EP
0 823 262 Feb 1998 EP
0 865 772 Sep 1998 EP
0 865 773 Sep 1998 EP
0 521 595 May 1999 EP
0 917 885 May 1999 EP
0 937 481 Aug 1999 EP
0 790 066 Apr 2000 EP
0 608 853 Apr 2003 EP
0 935 947 Dec 2004 EP
0 934 141 Nov 2005 EP
0215173 Dec 2008 EP
2214354 Aug 1989 GB
2257269 Jan 1993 GB
58-8522 Jan 1983 JP
60091858 May 1985 JP
61022752 Jan 1986 JP
62023361 Jan 1987 JP
62089470 Apr 1987 JP
62299277 Dec 1987 JP
6393516 Apr 1988 JP
63-181774 Jul 1988 JP
63217966 Sep 1988 JP
1089956 Apr 1989 JP
1135363 May 1989 JP
1158936 Jun 1989 JP
2107268 Apr 1990 JP
3081831 Apr 1991 JP
03-122850 Dec 1991 JP
4061840 Feb 1992 JP
4099963 Mar 1992 JP
4213069 Aug 1992 JP
4213070 Aug 1992 JP
4236965 Aug 1992 JP
5149969 Jun 1993 JP
5-506806 Oct 1993 JP
5-309159 Nov 1993 JP
5-507857 Nov 1993 JP
6-501179 Feb 1994 JP
631749 Apr 1994 JP
6169996 Jun 1994 JP
6-63224 Sep 1994 JP
6312313 Nov 1994 JP
728562 May 1995 JP
7124164 May 1995 JP
7124263 May 1995 JP
7136280 May 1995 JP
7148264 Jun 1995 JP
7505561 Jun 1995 JP
7037199 Jul 1995 JP
7185009 Jul 1995 JP
7255855 Oct 1995 JP
7275366 Oct 1995 JP
751067 Nov 1995 JP
8-229888 Sep 1996 JP
8509141 Oct 1996 JP
8317988 Dec 1996 JP
9000164 Apr 1997 JP
9-276413 Oct 1997 JP
9276413 Oct 1997 JP
9-294813 Nov 1997 JP
9294813 Nov 1997 JP
10-118193 May 1998 JP
10328191 Dec 1998 JP
11-267224 Oct 1999 JP
2000-197704 Jul 2000 JP
2000-510722 Aug 2000 JP
2000-511083 Aug 2000 JP
2001-500808 Jan 2001 JP
3325828 Jul 2002 JP
2002-529137 Sep 2002 JP
2002-542901 Dec 2002 JP
2002-543896 Dec 2002 JP
2003-517893 Jun 2003 JP
3649604 Feb 2005 JP
2005-534407 Nov 2005 JP
712908 Jan 1980 SU
758421 Aug 1980 SU
1529365 Dec 1989 SU
WO 9002520 Mar 1990 WO
WO 9113364 Sep 1991 WO
WO 9204072 Mar 1992 WO
WO 9207619 May 1992 WO
WO 9304722 Mar 1993 WO
WO 9311313 Jun 1993 WO
WO 9524236 Sep 1995 WO
WO 9619255 Jun 1996 WO
9638193 Dec 1996 WO
WO 9710022 Mar 1997 WO
WO 9725914 Jul 1997 WO
WO 9743949 Nov 1997 WO
WO 9744083 Nov 1997 WO
WO 9744086 Nov 1997 WO
WO 9810694 Mar 1998 WO
WO 9904847 Feb 1999 WO
WO 9911313 Mar 1999 WO
WO 0027303 May 2000 WO
WO 0030710 Jun 2000 WO
WO 0045885 Aug 2000 WO
WO 0048645 Aug 2000 WO
WO 0057943 Oct 2000 WO
WO 0066199 Nov 2000 WO
WO 0067845 Nov 2000 WO
WO 0072907 Dec 2000 WO
WO 0128620 Apr 2001 WO
WO 0136034 May 2001 WO
0145912 Jun 2001 WO
WO 0145773 Jun 2001 WO
WO 0193920 Dec 2001 WO
WO 0213682 Feb 2002 WO
WO 02062540 Aug 2002 WO
WO 03004086 Jan 2003 WO
WO 03008148 Jan 2003 WO
03041783 May 2003 WO
2004012804 Feb 2004 WO
WO 04012804 Feb 2004 WO
WO 2004012804 Feb 2004 WO
WO 04033015 Apr 2004 WO
WO 2004033015 Apr 2004 WO
2004047899 Jun 2004 WO
WO 04093957 Nov 2004 WO
WO 2004093957 Nov 2004 WO
2007050718 May 2007 WO
2008034010 Mar 2008 WO
Non-Patent Literature Citations (1)
Entry
“Mechanical Design and Systems Handbook”, H.A. Rothbart, 1964, p. 33-13 (one sheet).
Related Publications (1)
Number Date Country
20090043283 A1 Feb 2009 US